The effect of oral aluminium salts on the bone of non-dialysed uremic patients

J. G. Heaf*, J. Pødenphant, P. Joffe, J. R. Andersen, S. Fugleberg, O. Braendstrup

*Corresponding author af dette arbejde

    Publikation: Bidrag til tidsskriftArtikelForskningpeer review


    12 patients with conservatively treated uremia were investigated using bone histomorphometry, bone aluminium concentration determination and total body bone mineral content (TBBM). The bone aluminium was raised in 10 patients and was significantly related to oral aluminium salt consumption (p<0.01). Two of four patients who had not received aluminium also had raised levels but the difference was not significant from nonuremic patients. The two patients with the highest levels had a mineralisation defect despite normal levels of 1, 25-dihydroxyvitamin D. Three patients had significant bone loss of whom one had osteomalacia (OM) while two had secondary hyperparathyroidism (2HP). It is concluded that 1) aluminium salt consumption results in bone aluminium accumulation, and may contribute to the mineralisation defect; 2) uremic patients not treated ith aluminium salts may have slightly raised levels, but this seems not to be clinically important; 3) secondary hyperparthyroidism causes greater destruction of bone mass than other uremic bone diseaes; 4) atomic absorption spectrometry is a more sensitive method for detecting aluminium bone deposition than histochemical methods.

    Sider (fra-til)229-233
    Antal sider5
    TidsskriftScandinavian Journal of Urology and Nephrology
    Udgave nummer3
    StatusUdgivet - 1 jan. 1987


    Udforsk hvilke forskningsemner 'The effect of oral aluminium salts on the bone of non-dialysed uremic patients' indeholder.